Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- calcium acetate / magnesium carbonate
- pexidartinib
Interactions between your drugs
magnesium carbonate pexidartinib
Applies to: calcium acetate / magnesium carbonate, pexidartinib
Talk to your doctor before using pexidartinib together with magnesium carbonate. Magnesium carbonate can interfere with the absorption of pexidartinib and reduce its effectiveness if they are taken too close together. In some cases, your doctor may want to prescribe alternatives that do not interact. Otherwise, you may be able to minimize the interaction by taking pexidartinib at least 2 hours before or 2 hours after magnesium carbonate. Contact your doctor if your condition worsens during treatment with these medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
pexidartinib food
Applies to: pexidartinib
You may experience reduced absorption of pexidartinib in the presence of food. Pexidartinib should be taken on an empty stomach at least 1 hour before or 2 hours after food. This will make it easier for your body to absorb the medication. Also, while taking pexidartinib, you should avoid grapefruits and grapefruit juice. Grapefruit and grapefruit juice can raise the levels of pexidartinib in your body and lead to potentially dangerous adverse effects. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Amphojel
Amphojel is used for duodenal ulcer, erosive esophagitis, gastrointestinal hemorrhage, GERD ...
Auryxia
Auryxia is used for hyperphosphatemia of renal failure, iron deficiency anemia
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Fosrenol
Fosrenol (lanthanum carbonate) reduces phosphate levels in patients with end stage renal disease ...
Renagel
Renagel (sevelamer) is used to reduce levels of phosphorus in people with kidney disease who are on ...
Renvela
Renvela (sevelamer) reduces blood levels of phosphorus in people with chronic kidney disease who ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.